By Katherine Hamilton
Kenvue is eliminating 3.5% of its workforce as part of a broader effort to cut costs ahead of its planned acquisition by Kimberly-Clark.
The Tylenol maker said Tuesday the job cuts are part of a restructuring plan to optimize its operating model, transform its supply chain, reduce complexity and drive operational efficiencies.
The plan is expected to result in $250 million in expenses during 2026.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
February 17, 2026 17:29 ET (22:29 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.